Trending Now
Citius Pharmaceuticals Inc. (NASDAQ: CTXR) Completes Patients Recruitment In Phase 3...
Citius Pharmaceuticals Inc. (NASDAQ: CTXR) has completed patient recruitment in the pivotal third phase study of I/ONTAK, which is an engineered IL-2-diphtheria toxin fusion...
Aclaris Therapeutics (ACRS): Strategic Alliance with Biosion Ignites 53% Stock Surge
Aclaris Therapeutics, Inc. (NASDAQ: ACRS) experienced a remarkable 53.17% spike in its stock price, closing at $3.14 on November 18, 2024, following...
Sintx Technologies, Inc. (SINT): A Bold Move with Strategic Stock Repurchase...
Sintx Technologies, Inc. (NASDAQ: SINT), a leader in advanced ceramics for medical and technical applications, made headlines on November 18, 2024, with...
Popular News
Arbutus Biopharma Corporation (NASDAQ: ABUS) and Antios Therapeutics Inc. Dose First...
Arbutus Biopharma Corporation (NASDAQ: ABUS) and Antios Therapeutics Inc. have announced the dosing of the first patient in triple combination treatment in chronic hepatitis...
MAKE IT MODERN
LATEST REVIEWS
Competing Narratives and the Future of CorMedix Inc. (NYSEAMERICAN:CRMD)
CorMedix Inc.
(NYSEAMERICAN:CRMD) is still largely about Neutrolin, the company’s prize asset
targeting the reduction and prevention of catheter-related infections and
thrombosis in patients requiring...
MAKE IT MODERN
PERFORMANCE TRAINING
Acadia Pharmaceuticals (NASDAQ:ACAD) Reports NUPLZID® Net Sales Of $120.6 Million In Q3 2020
Acadia Pharmaceuticals (NASDAQ:ACAD) has announced its Q3 2020 financial results in which net sales were up 27% YoY to $120.6 million.
Pimavanserin sales drove Acadia’s...
Vericel Corporation (NASDAQ: VCEL) Signs Long-Term Lease Contract For New Ultramodern Cell Therapy Production...
Vericel Corporation (NASDAQ: VCEL) has announced the signing of a long-term lease contract for a new ultramodern advanced cell therapy production facility and corporate...
The Virus Testing Stocks Pullback Opportunity (CODX, FLGT, ALST, LH)
The world exploded with a cheer of joy on Monday of this week as Pfizer put out extremely encouraging news about its top coronavirus...
Iovance Biotherapeutics Inc. (NASDAQ:IOVA) Releases Cohort 4 C-144-01 Study Data In Advanced Melanoma
Iovance Biotherapeutics Inc. (NASDAQ:IOVA) has announced preliminary data from vital Cohort 4 as well as updated Cohort 2 data in its C-144-01 lifileucel study...
ProQR Therapeutics N.V. (NASDAQ: PRQR) Signs Licensing and Research Agreement With Lilly for Axiomer...
ProQR Therapeutics N.V. (NASDAQ: PRQR) has announced a worldwide licensing and research agreement with Eli Lilly and Company to discover, produce, and commercial possible...
MAKE IT MODERN
